Article info
PDFOriginal research
Accessing unproven interventions in the COVID-19 pandemic: discussion on the ethics of ‘compassionate therapies’ in times of catastrophic pandemics
- Correspondence to Dr Shlomit Zuckerman, School of Public Health, Department of Disaster Medicine, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv 9190501, Israel; shlomit.zuckerman{at}mail.huji.ac.il
Citation
Accessing unproven interventions in the COVID-19 pandemic: discussion on the ethics of ‘compassionate therapies’ in times of catastrophic pandemics
Publication history
- Received August 9, 2020
- Accepted September 26, 2021
- First published October 13, 2021.
Online issue publication
May 19, 2023
Article Versions
- Previous version (28 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- The Ebola clinical trials: a precedent for research ethics in disasters
- WHO guidance on ethics in outbreaks and the COVID-19 pandemic: a critical appraisal
- If it walks like a duck…: Monitored Emergency Use of Unregistered and Experimental Interventions (MEURI) is research
- Building a new platform to support public health emergency response in Africa: the AFENET Corps of Disease Detectives, 2018–2019
- Managing enduring public health emergencies such as COVID-19: lessons from Uganda Red Cross Society’s Ebola virus disease response operation
- Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making
- The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo
- Investing in preparedness for rapid detection and control of epidemics: analysis of health system reforms and their effect on 2021 Ebola virus disease epidemic response in Guinea
- Prevalence and risk factors of depression symptoms among rural and urban populations affected by Ebola virus disease in the Democratic Republic of the Congo: a representative cross-sectional study
- Risk communication and community engagement capacity in the Eastern Mediterranean Region: a call for action